Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,709Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1AKTINOS PHARMA PRIVATE LIMITED

02 1Aurobindo Pharma Limited

03 1Chromo Laboratories India Private Limited

04 1DARMERICA, LLC

05 1Dasami Lab Private Limited

06 1Dr. Reddy's Laboratories Limited

07 2Fagron Inc

08 2Glenmark Life Sciences Limited

09 1Hainan Poly Pharm. Co., Ltd.

10 1Hetero Labs Limited

11 1Jubilant Pharmova Limited

12 1M/s. Lee Pharma Limited

13 1MSN Laboratories Private Limited

14 1MYLAN LABORATORIES LIMITED

15 1Maithri Drugs Private Limited

16 1Medichem S.A.

17 1Patheon Manufacturing Services LLC

18 1Pfizer Ireland Pharmaceuticals Unlimited Company

19 1Professional Compounding Centers of America

20 1SIONC PHARMACEUTICALS PVT LTD

21 1Tianish Laboratories Private Limited

22 1Yung Shin Pharm. Ind. Co., Ltd.

23 1ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

VORICONAZOLE

NDC Package Code : 52562-001

Start Marketing Date : 2017-04-12

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

VORICONAZOLE

NDC Package Code : 51552-1573

Start Marketing Date : 2019-04-15

End Marketing Date : 2026-03-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

VORICONAZOLE

NDC Package Code : 51552-1524

Start Marketing Date : 2016-09-15

End Marketing Date : 2026-03-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

VORICONAZOLE

NDC Package Code : 14335-450

Start Marketing Date : 2023-09-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (20kg/20kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

VORICONAZOLE

NDC Package Code : 53296-0081

Start Marketing Date : 2010-05-27

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (75kg/75kg)

Marketing Category : BULK INGREDIENT

blank

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

VORICONAZOLE

NDC Package Code : 14501-0014

Start Marketing Date : 2010-03-26

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

VORICONAZOLE

NDC Package Code : 60715-1700

Start Marketing Date : 2019-01-01

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

VORICONAZOLE

NDC Package Code : 63126-911

Start Marketing Date : 2019-10-24

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

09

Dr. Reddy's Laboratories Limited

Country
Aus. Peptide Conference
Not Confirmed
arrow

Dr. Reddy's Laboratories Limited

Country
arrow
Aus. Peptide Conference
Not Confirmed

VORICONAZOLE

NDC Package Code : 55111-099

Start Marketing Date : 2011-09-30

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

10

Professional Compounding Centers of...

Country
Aus. Peptide Conference
Not Confirmed
arrow

Professional Compounding Centers of...

Country
arrow
Aus. Peptide Conference
Not Confirmed

VORICONAZOLE

NDC Package Code : 51927-5286

Start Marketing Date : 2025-09-03

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT FOR HUMAN P...

blank

Looking for 137234-62-9 / Voriconazole API manufacturers, exporters & distributors?

Voriconazole manufacturers, exporters & distributors 1

68

PharmaCompass offers a list of Voriconazole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Voriconazole manufacturer or Voriconazole supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Voriconazole manufacturer or Voriconazole supplier.

PharmaCompass also assists you with knowing the Voriconazole API Price utilized in the formulation of products. Voriconazole API Price is not always fixed or binding as the Voriconazole Price is obtained through a variety of data sources. The Voriconazole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Voriconazole

Synonyms

137234-62-9, Vfend, (2r,3s)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol, Uk-109496, (+/-)-voriconazole, Voriconazole vfend

Cas Number

137234-62-9

Unique Ingredient Identifier (UNII)

USG4B1CD29

About Voriconazole

A triazole antifungal agent that specifically inhibits STEROL 14-ALPHA-DEMETHYLASE and CYTOCHROME P-450 CYP3A.

(alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol Manufacturers

A (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol, including repackagers and relabelers. The FDA regulates (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

(alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol Suppliers

A (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol supplier is an individual or a company that provides (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol active pharmaceutical ingredient (API) or (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol finished formulations upon request. The (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol suppliers may include (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol API manufacturers, exporters, distributors and traders.

click here to find a list of (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

(alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol suppliers with NDC on PharmaCompass.

(alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol Manufacturers | Traders | Suppliers

(alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol Manufacturers, Traders, Suppliers 1
36

We have 18 companies offering (alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol

Get in contact with the supplier of your choice:

  1. Aktinos
  2. Alivus Life Sciences
  3. Aurobindo Pharma Limited
  4. Chromo Laboratories
  5. Dasami Lab
  6. Fagron Group
  7. Hainan Poly Pharm
  8. Hetero Drugs
  9. Jubilant Pharmova
  10. Medichem S.A
  11. MSN Laboratories
  12. Patheon
  13. Pfizer Inc
  14. Sionc Pharmaceuticals
  15. Tianish Laboratories
  16. Viatris
  17. Yung Shin Pharm Industrial
  18. Zhejiang Huahai Pharmaceutical
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.